The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Home

Found 358 results
Filters: Author is Anushka Patel
2014
, Webster RJ, Singh K, Jan S, et al. TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. American Heart Journal. 2014;167:127-32.
Patel B, Usherwood T, Harris M, et al. Understanding the impact of a multifaceted quality improvement intervention to improve cardiovascular disease risk management in Australian Primary Health Care: the TORPEDO study process evaluation [poster presentation]. In: World Congress of Cardiology (WCC). World Congress of Cardiology (WCC). Melbourne, Australia; 2014.
2013
Praveen D, Patel A, Macmahon S, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Praveen D, Patel A, Macmahon S, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes mellitus and cardiovascular disease or risk factors: The ADVANCE Study. Diabetes. 2013.
Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA. 2013;310(9):918-29. doi:10.1001/jama.2013.277064.
Chalmers J, Arima H, Woodward M, et al. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial. Hypertension. 2013.
Hata J, Arima H, Zoungas S, et al. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLOS ONE. 2013;8.
Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial. Circulation. 2013;128:1325-34.
Stefansdottir G, Zoungas S, Chalmers J, et al. Erratum to : Intensive glucose control and risk of cancer patients with type 2 diabetes. Diabetologia. 2013.
Patel A. Health management and policy aspects of cardiovascular diseases [Invited speaker]. In: Wellcome Trust Frontiers Meeting: The Growing Global Health Burden of Non-Communicable Diseases. Wellcome Trust Frontiers Meeting: The Growing Global Health Burden of Non-Communicable Diseases. London, United Kingdom; 2013.
van Dieren S, Kengne A, Chalmers J, et al. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial. Diabetes, Obesity and Metabolism. 2013.
Perkovic V, Heerspink HL, Chalmers J, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International. 2013;83:517-23.
, Stewart F, Singh K, Laba TL, et al